Curaleaf (OTCMKTS:CURLF) Trading Down 9.6% – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) dropped 9.6% during mid-day trading on Friday . The stock traded as low as $3.5401 and last traded at $3.5601. Approximately 591,742 shares were traded during trading, a decline of 42% from the average daily volume of 1,024,857 shares. The stock had previously closed at $3.94.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

Curaleaf Trading Down 13.4%

The stock has a market capitalization of $2.38 billion, a P/E ratio of -26.26 and a beta of 1.58. The firm’s 50 day moving average price is $2.76 and its 200 day moving average price is $2.64. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of ($0.08) by $0.17. The firm had revenue of $324.23 million during the quarter, compared to the consensus estimate of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. As a group, equities research analysts expect that Curaleaf Holdings, Inc. will post -0.12 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.